GlassScriptPhysician profile
Oscar M Ramirez
NPI 1851424386
$788.28
in general payments reported to CMS, 2019-2025
6 companies · $214 in 2025
The $214 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2021: $37.71 · 2023: $330 · 2024: $79.46 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $623.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $207.62 | 2023 | |
| Avita Medical Americas, LLC | $169.10 | 2025 | Recell, Cohealyx, Permeaderm |
| Integra Lifesciences Corporation | $147.12 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Allergan, INC. | $144.02 | 2019-2021 | |
| Dilon Technologies, INC. | $99.42 | 2024-2025 | Hemoblast Bellows |
| Johnson & Johnson Health Care Systems INC. | $21.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oscar Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.